Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Tribute Pharmaceuticals Canada Inc (ARZ.TO)

DON'T BUY

Hold off buying Hecla now. They were looking for accretive cash flow from the acquisition.

BUY
(Market Call Minute.) Good, stable jurisdiction in Quebec.
DON'T BUY
It is pretty common for gold stocks to go down with the price of gold and then to not go up with it again.
COMMENT
This one tends to be a bit of a trader as it has a lot of periods when it tends to go sideways. Have done a good job of developing the Casa Berardi mine but some disappointment in how much they have ramped it up. He’ll continue trading it.
HOLD
Gold stocks have some room to pull back. Produces about 150,000 ounces a year with potential for exploration and development success.
HOLD
Ontario gold producer. Good growing production profile. Recent weakness is because of the weakness in gold. Potential takeout prospect.
COMMENT
The only gold stocks that held up really well are those that are in prominent indexes. Smaller gold stocks are in gold funds and are under pressure for reasons that have nothing to do with the underlying operations of the company.
TOP PICK
Really good project in northern Quebec. Will be producing at a rate of about 160,000 ounces a year. Catch costs of around $280 an ounce. Has another discovery called Joanna near Rouyn-Noranda, Quebec and is likely to be a very large open pit bulk mining gold. Undervalued on the Casa Berardi mine alone.
PAST TOP PICK
(A Top Pick Nov 20/06. Up 8.7%.) Owned this one specifically as a takeout. Took some profits. Have a great asset and ultimately someone will buy or merge with them.
PAST TOP PICK
(A Top Pick Oct 4/06. Up 15.7%.) Northwestern Quebec. Still likes it a lot. In production.
TOP PICK
Market cap of over 1/2 billion dollars. Very undervalued. Also have a new discovery.
PAST TOP PICK
(A Top Pick Feb 15/06. Up 98.4%.) In Quebec. Still has more to go.
BUY
Low current production, but ramping up in fairly short order. Located in North America. Reserve/resource of about 3.5 million ounces. Prefers Western Gold Fields (WGI-T).
BUY
Stock has performed very well over the last year, because they put their Quebec mine back in production. The market has still not realized the full value of this mine.
HOLD
A very hot stock.
Showing 1 to 15 of 26 entries

Tribute Pharmaceuticals Canada Inc (ARZ.TO) Frequently Asked Questions

What is Tribute Pharmaceuticals Canada Inc stock symbol?

Tribute Pharmaceuticals Canada Inc is a OTC stock, trading under the symbol ARZ.TO (previously ARZ-T on Stockchase) on the undefined (undefined). It is usually referred to as or ARZ.TO

Is Tribute Pharmaceuticals Canada Inc a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on ARZ.TO (previously ARZ-T on Stockchase) on Stockchase. Read the latest expert commentary for Tribute Pharmaceuticals Canada Inc.

Is Tribute Pharmaceuticals Canada Inc a good investment or a top pick?

Tribute Pharmaceuticals Canada Inc was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Tribute Pharmaceuticals Canada Inc.

Why is Tribute Pharmaceuticals Canada Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Tribute Pharmaceuticals Canada Inc.

Is Tribute Pharmaceuticals Canada Inc worth watching?

Tribute Pharmaceuticals Canada Inc is covered by Stockchase experts and is worth watching.